Aaron I. Davis

CIK 1465914 · last filed 2024-10-28

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$391.12M

Companies

6

Total Filings

45

Lifetime Open-Market Net

$118.31M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TNGX Director 6,799,435 $30.94 $210.37M $5.59M 8 2024-10-28
iTeos Therapeutics, Inc. (ITOS) Delisted Director 4,815,754 $10.15 $48.88M -$18.27M 11 2024-06-13
TYRA 10%+ Owner 6,534,298 $26.99 $176.36M $43.00M 3 2024-02-08
RAIN Director 2,147,212 $2.04 $4.38M $45.36M 5 2024-01-26
Mirati Therapeutics, Inc. (MRTX) Delisted Director 1,572,368 $58.70 $92.30M -$2.38M 9 2024-01-23
Odonate Therapeutics, Inc. (ODT) Delisted Director 5,232,842 $1.12 $5.86M $44.99M 9 2021-11-19

Recent Filings · Page 3 of 5

45 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-06-10 iTeos Therapeutics, Inc. (ITOS) Delisted Grant (A) $0 EDGAR
2022-05-11 iTeos Therapeutics, Inc. (ITOS) Delisted Sell (S) −663,000 -$13.95M EDGAR
2022-05-02 iTeos Therapeutics, Inc. (ITOS) Delisted Sell (S) −375,000 -$10.25M EDGAR
2022-03-24 iTeos Therapeutics, Inc. (ITOS) Delisted Buy (P) +50,000 $1.63M EDGAR
2022-01-18 Mirati Therapeutics, Inc. (MRTX) Delisted Grant (A) +2,546 $0 EDGAR
2021-11-19 Odonate Therapeutics, Inc. (ODT) Delisted Sell (S) −1,200,000 -$2.50M EDGAR
2021-09-17 TYRA Mixed +33,057,270 $50.00M EDGAR
2021-06-21 iTeos Therapeutics, Inc. (ITOS) Delisted Grant (A) $0 EDGAR
2021-04-27 RAIN Mixed +2,350,000 $39.70M EDGAR
2021-01-20 Mirati Therapeutics, Inc. (MRTX) Delisted Grant (A) +1,475 $0 EDGAR
Showing 2130 of 45
Page 3 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.